![]() Colorectal cancers are among other neoplasms on the third place in morbidity and mortality after the breast and lung and bronchus cancers in women and prostate and lung and bronchus cancers in men. Neoplasmal diseases are the second, or according to some authors, the third cause of deaths all over the world just after the cardiovascular and infectious diseases, and just before communication accidents. ![]() ![]() We did not find any other correlations between the level of v5 and v6 CD44 variants and other evaluated parameters.ĬONCLUSION: The level of CD44 v5 and v6 estimated by ELISA test in the serum can not be used as a prognostic factor in colorectal cancer. RESULTS: Only the level of CD44 v5 in the serum of patients before operation with G2 pT4 tumour was lower than that in other probes and the difference was statistically significant. ![]() pT stage and grade of malignancy of the tumour were examined in formalin fixed and paraffin embedded materials obtained during operation. METHODS: The serum obtained from 114 persons with colorectal adenocarcinomas was examined using ELISA method. AIM: This study was designed to compare the levels of v5 and v6 splice variants of CD44 evaluated using ELISA test in the serum of patients with colorectal cancer in different stages of progression of the disease estimated in pT stage according to WHO score, histopathological grade of malignancy and some clinicopathological features.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |